Refining Patient Reported Outcomes
Saul Shiffman, Ph.D.
– Senior Scientific Consultant
Dr. Shiffman is a Professor of Psychology (Clinical and Health Psychology) at the Universityof Pittsburgh. He is widely published on scientific methods for collecting data on real-world behavior and experience. With Dr. Arthur Stone, he has defined the Ecological Momentary Assessment (EMA) approach to data collection. Dr. Shiffman has edited several special sections of leading health journals on these methods. He developed the first palm-top computer solution for collecting EMA diary data. In addition to serving on scientific panels for the National Institutes of Health, he has served as aconsultant to the pharmaceutical industry and a site investigator for over a decade. Most recently, Dr. Shiffman was the winner of the Good Clinical Practice Journal’s Lifetime Achievement Award.
Where to find Saul:
Improving Measure Sensitivity in Early Stage Research
Based on regulatory guidance, Phase II is the appropriate time to develop and validate PRO measures, making ePRO a logical fit earlier in the clinical development lifecycle. This session will cover the advantages of incorporating electronic PRO capture methods in Phase II or early stage development studies.
Thursday, June 18 - 10 AM EST
Saul Shiffman, PhD, Chief Science Officer
invivodata, inc.